Secrecy or transparency? Why the future of #clinicaltrials data should be open https://t.co/2lSGxlUK9s *sub req #opendata #opengov #pharma https://t.co/Bqr0vmeKYt
RT @CMAJ: Why Health Canada should publish #clinicaltrials reports https://t.co/jE27zA06Wh *sub req #opendata #opengov @iqwig https://t.co/…
RT @CMAJ: Why Health Canada should publish #clinicaltrials reports https://t.co/jE27zA06Wh *sub req #opendata #opengov @iqwig https://t.co/…
Why Health Canada should publish #clinicaltrials reports https://t.co/jE27zA06Wh *sub req #opendata #opengov @iqwig https://t.co/BpIAXtubn3
RT @CMAJ: Why the @US_FDA & @HealthCanada should publish the #clinicaltrials of drugs submitted for approval: https://t.co/H6EoL1wCXX *sub…
RT @CMAJ: Why the @US_FDA & @HealthCanada should publish the #clinicaltrials of drugs submitted for approval: https://t.co/H6EoL1wCXX *sub…
RT @CMAJ: Why the @US_FDA & @HealthCanada should publish the #clinicaltrials of drugs submitted for approval: https://t.co/H6EoL1wCXX *sub…
RT @cmrherder: Critical call upon regulators to publish CSRs | @TrudoLemmens + I argue @HealthCanada can/should follow EMA's lead https://t…
RT @CADTH_ACMTS: Much to consider: "Secrecy or transparency? The future of regulatory trial data" https://t.co/mf2mvHfDUk Thx @cmrherder #H…
Much to consider: "Secrecy or transparency? The future of regulatory trial data" https://t.co/mf2mvHfDUk Thx @cmrherder #HTA @TammyJClifford https://t.co/Tydpql511f
RT @cmrherder: 1 | A few more thoughts about @CMAJ new articles re: making Rx evidence held by @HealthCanada transparent https://t.co/RJH4k…
1 | A few more thoughts about @CMAJ new articles re: making Rx evidence held by @HealthCanada transparent https://t.co/RJH4k4Rxgz
My favorite thing about this? It's an HTA body (IQWiG author) pushing for regulatory transparency https://t.co/RJH4k4Rxgz | CC @CADTH_ACMTS
RT @cmrherder: Critical call upon regulators to publish CSRs | @TrudoLemmens + I argue @HealthCanada can/should follow EMA's lead https://t…
Critical call upon regulators to publish CSRs | @TrudoLemmens + I argue @HealthCanada can/should follow EMA's lead https://t.co/60m5jWEvxg https://t.co/q7vqXaYD5k
As open data! https://t.co/NhPf8VqIMD
RT @CMAJ: Why the @US_FDA & @HealthCanada should publish the #clinicaltrials of drugs submitted for approval: https://t.co/H6EoL1wCXX *sub…
Definitely @CMAJ #openaccess #opendata https://t.co/EZcxjKYtMA
Why the @US_FDA & @HealthCanada should publish the #clinicaltrials of drugs submitted for approval: https://t.co/H6EoL1wCXX *sub req https://t.co/JJBGXlqgcw